1
Short title
1 Short title
These regulations may be cited as the Public Health (Smoking Product Licence) Regulations 2019 .
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Tasmania regulation
These regulations change the licence rules for selling vaping and tobacco products. They make supply of vaping liquids conditional on a valid prescription, require sellers to keep invoices, comply with the Poisons Act, get director approval to dispose of devices, and provide records to authorised officers. They also set licence fees: a high fee for tobacco licences (717 fee units per premises) and no fee for personal vaporiser licences. This affects retailers and prescribers by shifting compliance costs onto licence-holders and concentrating decision power with regulators and authorised officers.
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in Public Health (Smoking Product Licence) Regulations 2019.
These regulations may be cited as the Public Health (Smoking Product Licence) Regulations 2019 .
These regulations take effect on 25 November 2019.
In these regulations –
Act means the Public Health Act 1997 .
[Regulation 4 Substituted by S.R. 2026, No. 10, Applied:11 Mar 2026]
(1) For section 74C(4A) of the Act, the following conditions apply to all smoking product licences relating to personal vaporiser products:
(a) a person may only supply a personal vaporiser product that is a vaping substance to another person (the patient) in accordance with a prescription for the supply of the substance to the patient issued by either of the following in accordance with the Poisons Act 1971 (a valid prescription):
(i) a medical practitioner;
(ii) an authorised health professional who is a nurse practitioner;
(b) a person may only sell a personal vaporiser product other than a vaping substance to a patient if satisfied that the patient –
(i) has a valid prescription for the supply of a vaping substance to be used in connection with the personal vaporiser product; or
(ii) has in the last 12 months been supplied, in accordance with a valid prescription, a vaping substance to be used in connection with the personal vaporiser product;
(c) a person must comply with the Act and the Poisons Act 1971 in supplying a personal vaporiser product in accordance with a valid prescription;
(d) a person may only, under the authority of the licence, dispose of a personal vaporiser product other than by supply with the prior approval of the Director;
(e) the holder of the licence must keep any invoice for the sale of a personal vaporiser product for at least 2 years after the sale;
(f) the holder of the licence must provide any information or documentation held in respect of the licence and the personal vaporiser products in the possession of, or sold or otherwise disposed of by, the holder of the licence if requested to do so by a person appointed or authorised under –
(i) section 23 of the Poisons Act 1971 ; or
(ii) section 27 of the Therapeutic Goods Act 2001 .
(2) Unless a contrary intention appears, a term used in this regulation has the same meaning as in the Poisons Act 1971 .
(3) In this regulation –
vaping substance means a substance referred to in paragraph (c) of the definition of personal vaporiser product in section 3 of the Act, whether or not that substance is a scheduled substance.
[Regulation 5 Inserted by S.R. 2026, No. 10, Applied:11 Mar 2026] For sections 74B(3)(c) and 74F(2)(b) of the Act, the prescribed fee for an application for a smoking product licence, or the renewal of a smoking product licence, is –
(a) if the application relates to a tobacco product – 717 fee units for each premises specified in the application; or
(b) if the application relates to a personal vaporiser product – 0 fee units.
Displayed and numbered in accordance with the Rules Publication Act 1953.
Notified in the Gazette on 6 November 2019
These regulations are administered in the Department of Health.
Sourced from Tasmanian Legislation Online (legislation.tas.gov.au), CC BY 4.0.
These regulations may be cited as the Public Health (Smoking Product Licence) Regulations 2019 .
These regulations take effect on 25 November 2019.
In these regulations –
Act means the Public Health Act 1997 .
[Regulation 4 Substituted by S.R. 2026, No. 10, Applied:11 Mar 2026]
(1) For section 74C(4A) of the Act, the following conditions apply to all smoking product licences relating to personal vaporiser products:
(a) a person may only supply a personal vaporiser product that is a vaping substance to another person (the patient) in accordance with a prescription for the supply of the substance to the patient issued by either of the following in accordance with the Poisons Act 1971 (a valid prescription):
(i) a medical practitioner;
(ii) an authorised health professional who is a nurse practitioner;
(b) a person may only sell a personal vaporiser product other than a vaping substance to a patient if satisfied that the patient –
(i) has a valid prescription for the supply of a vaping substance to be used in connection with the personal vaporiser product; or
(ii) has in the last 12 months been supplied, in accordance with a valid prescription, a vaping substance to be used in connection with the personal vaporiser product;
(c) a person must comply with the Act and the in supplying a personal vaporiser product in accordance with a valid prescription;
(d) a person may only, under the authority of the licence, dispose of a personal vaporiser product other than by supply with the prior approval of the Director;
(e) the holder of the licence must keep any invoice for the sale of a personal vaporiser product for at least 2 years after the sale;
(f) the holder of the licence must provide any information or documentation held in respect of the licence and the personal vaporiser products in the possession of, or sold or otherwise disposed of by, the holder of the licence if requested to do so by a person appointed or authorised under –
(i) section 23 of the Poisons Act 1971 ; or
(ii) section 27 of the Therapeutic Goods Act 2001 .
(2) Unless a contrary intention appears, a term used in this regulation has the same meaning as in the Poisons Act 1971 .
(3) In this regulation –
vaping substance means a substance referred to in paragraph (c) of the definition of personal vaporiser product in section 3 of the Act, whether or not that substance is a scheduled substance.
[Regulation 5 Inserted by S.R. 2026, No. 10, Applied:11 Mar 2026] For sections 74B(3)(c) and 74F(2)(b) of the Act, the prescribed fee for an application for a smoking product licence, or the renewal of a smoking product licence, is –
(a) if the application relates to a tobacco product – 717 fee units for each premises specified in the application; or
(b) if the application relates to a personal vaporiser product – 0 fee units.
Displayed and numbered in accordance with the Rules Publication Act 1953.
Notified in the Gazette on 6 November 2019
These regulations are administered in the Department of Health.